130 related articles for article (PubMed ID: 35212453)
1. Induction of apoptosis using ATN as a novel Yes-associated protein inhibitor in human oral squamous cell carcinoma cells.
Chu PC; Dokla EME; Hu JL; Weng JR
Environ Toxicol; 2022 Jun; 37(6):1404-1412. PubMed ID: 35212453
[TBL] [Abstract][Full Text] [Related]
2. Metformin inhibits mTOR and c-Myc by decreasing YAP protein expression in OSCC cells.
Wang Y; Zhang Y; Feng X; Tian H; Fu X; Gu W; Wen Y
Oncol Rep; 2021 Mar; 45(3):1249-1260. PubMed ID: 33650651
[TBL] [Abstract][Full Text] [Related]
3. Yes-associated protein promotes cell migration via activating Wiskott-Aldrich syndrome protein family member 1 in oral squamous cell carcinoma.
Qi L; Shi C; Li J; Xu S; Han Y; Li J; Zhang L
J Oral Pathol Med; 2019 Apr; 48(4):290-298. PubMed ID: 30697796
[TBL] [Abstract][Full Text] [Related]
4. The role of YAP in the control of the metastatic potential of oral cancer.
Ahmad US; Saravanan K; Wan H
Oncol Res; 2021; 29(6):377-391. PubMed ID: 37304649
[TBL] [Abstract][Full Text] [Related]
5. YAP signaling induces PIEZO1 to promote oral squamous cell carcinoma cell proliferation.
Hasegawa K; Fujii S; Matsumoto S; Tajiri Y; Kikuchi A; Kiyoshima T
J Pathol; 2021 Jan; 253(1):80-93. PubMed ID: 32985688
[TBL] [Abstract][Full Text] [Related]
6. Desmoglein-3 induces YAP phosphorylation and inactivation during collective migration of oral carcinoma cells.
Ahmad US; Parkinson EK; Wan H
Mol Oncol; 2022 Apr; 16(8):1625-1649. PubMed ID: 35000271
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemistry of YAP and dNp63 and survival analysis of patients bearing precancerous lesion and oral squamous cell carcinoma.
Ono S; Nakano K; Takabatake K; Kawai H; Nagatsuka H
Int J Med Sci; 2019; 16(5):766-773. PubMed ID: 31217745
[No Abstract] [Full Text] [Related]
8. Enhancement of Histone Deacetylase Inhibitor Sensitivity in Combination with Cyclin-Dependent Kinase Inhibition for the Treatment of Oral Squamous Cell Carcinoma.
Zhao B; Huang Z; Qin Z; Li Y; Wang T; Wang L; Zhou W; Yu C; Wang X; Yang S; Fan Y; Xiang R
Cell Physiol Biochem; 2019; 53(1):141-156. PubMed ID: 31237760
[TBL] [Abstract][Full Text] [Related]
9. Knocking-down of CREPT prohibits the progression of oral squamous cell carcinoma and suppresses cyclin D1 and c-Myc expression.
Ma J; Ren Y; Zhang L; Kong X; Wang T; Shi Y; Bu R
PLoS One; 2017; 12(4):e0174309. PubMed ID: 28369091
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic Effects of Perilla Phenols in Oral Squamous Cell Carcinoma.
Lee CH; Tsao YH; Weng YP; Wang IC; Chen YP; Hung PF
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834377
[TBL] [Abstract][Full Text] [Related]
11. LATS2 induced by TNF-alpha and inhibited cell proliferation and invasion by phosphorylating YAP in oral squamous cell carcinoma.
Dong C; Wei KJ; Zhang WB; Sun H; Pan HY; Zhang L
J Oral Pathol Med; 2015 Jul; 44(6):475-81. PubMed ID: 25782587
[TBL] [Abstract][Full Text] [Related]
12. miR-654-5p Targets GRAP to Promote Proliferation, Metastasis, and Chemoresistance of Oral Squamous Cell Carcinoma Through Ras/MAPK Signaling.
Lu M; Wang C; Chen W; Mao C; Wang J
DNA Cell Biol; 2018 Apr; 37(4):381-388. PubMed ID: 29364705
[TBL] [Abstract][Full Text] [Related]
13. A PKM2 inhibitor induces apoptosis and autophagy through JAK2 in human oral squamous cell carcinoma cells.
Weng JR; Gopula B; Chu PC; Hu JL; Feng CH
Chem Biol Interact; 2023 Aug; 380():110538. PubMed ID: 37164279
[TBL] [Abstract][Full Text] [Related]
14. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of Akt by methanol extracts of Impatiens balsamina L. promotes apoptosis in human oral squamous cell carcinoma cell lines.
Shin JA; Ryu MH; Kwon KH; Choi B; Cho SD
J Oral Pathol Med; 2015 Jul; 44(6):420-8. PubMed ID: 25212570
[TBL] [Abstract][Full Text] [Related]
16. CCN5 inhibits proliferation and promotes apoptosis of oral squamous cell carcinoma cells.
Sun S; Cui Z; Yan T; Wu J; Liu Z
Cell Biol Int; 2020 Apr; 44(4):998-1008. PubMed ID: 31889370
[TBL] [Abstract][Full Text] [Related]
17. GPR39 Overexpression in OSCC Promotes YAP-Sustained Malignant Progression.
Jiang Y; Li T; Wu Y; Xu H; Xie C; Dong Y; Zhong L; Wang Z; Zhao H; Zhou Y; Li J; Ji N; Zeng X; Feng X; Chen Q
J Dent Res; 2020 Jul; 99(8):949-958. PubMed ID: 32325008
[TBL] [Abstract][Full Text] [Related]
18. Combined cetuximab and celecoxib treatment exhibits a synergistic anticancer effect on human oral squamous cell carcinoma in vitro and in vivo.
Qian M; Qian D; Jing H; Li Y; Ma C; Zhou Y
Oncol Rep; 2014 Oct; 32(4):1681-8. PubMed ID: 25328959
[TBL] [Abstract][Full Text] [Related]
19. MARCH1 silencing suppresses growth of oral squamous cell carcinoma through regulation of PHLPP2.
Liu L; Guo B; Han Y; Xu S; Liu S
Clin Transl Oncol; 2022 Jul; 24(7):1311-1321. PubMed ID: 35122633
[TBL] [Abstract][Full Text] [Related]
20. Combination treatment with ferroptosis and autophagy inducers significantly inhibit the proliferation and migration of oral squamous cell carcinoma.
Zhang L; Li Z; Ma X; Yang W; Hao Y; Zhang L; Piao S
Biochem Biophys Res Commun; 2024 May; 709():149842. PubMed ID: 38554601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]